This timeframe is established through rigorous stability testing conducted during the drug development process, ensuring that the active pharmaceutical ingredient remains within acceptable potency limits throughout the stated expiration period
At 2.4 mg weekly (96 units), you get just over 2 doses per vial
In contrast, Bydureon is a long-acting, once-weekly formulation, developed using a microsphere-based delivery system
Tirzepatide (Zepbound/Mounjaro) is a newer dual-action GIP/GLP-1 agonist that targets two hormonal pathways for even greater results
Side Effects: Common: Nausea, vomiting, diarrhea, abdominal pain, and decreased appetite
Building your complete switching timeline Here is the full timeline from decision to results, consolidated into one reference: From your last semaglutide injection to reaching a therapeutic tirzepatide dose (7.5 to 10 mg) typically takes 9 to 13 weeks